samedan logo
 
 
 
spacer
home > pmps > autumn 2020 > medication adherence for the modern covid world
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Medication Adherence for the Modern COVID World

According to a survey by the Pharmaceutical Research and Manufacturers of America, its members spent roughly $79.6 billion on R&D in 2018 (1). That amount would make it the 70th largest country in terms of GDP. Itís well known that many of the compounds and drugs that make up that figure never go to market. However, even those that do, donít always achieve their full potential, simply because patients donít use them as directed.

The issue of medication adherence has been long discussed among the healthcare industry. Research shows one in four patients never pick up a prescription, and roughly half fail to take their medication as directed (2). The many health issues plaguing the population certainly canít be attributed to medication adherence, but its impact, to some degree, is undeniable.

Like any widespread issue, the nuances of medication adherence are seemingly endless. However, by examining subsets of this problem, such as vulnerable populations and proven efficacious strategies, there is progress to made.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Thomas Grinnan is Vice President, Sales and Marketing, Healthcare at Silgan Dispensing Systems. He has worked in the pharmaceutical industry for more than 28 years as an Executive, Innovator, Consultant, and Business Development Specialist. He began his career in strategic consulting, working closely with pharma and medical device companies and leveraging his university training in biological sciences. After a long career at Westvaco, MeadWestvaco, and Westrockís Healthcare and Patient Adherence packaging divisions, Thomas joined Silgan Dispensing Systems, a spin-off specialising in liquid dispensing solutions for nasal, topical, and ophthalmic delivery. He resides in Richmond, US, but has worked and lived in Europe often throughout his career.
spacer
Thomas Grinnan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Novasep to sell its chromatography equipment division to Sartorius

06 Jan 2021 ē A disposal aligned with Novasepís core strategy ē An opportunity for Novasepís chromatography equipment division to accelerate its growth by joining an established leader in the sector
More info >>

White Papers
 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement